Global Women’s Health Drugs Market to 2024 – Influx of New Products Including Orilissa, Relugolix and Bremelanotide

Global Women’s Health Drugs Market to 2024 Research Report provides Key Marketed Products, Pipeline Landscape Assessment, Company Analysis and Positioning, Revenue and Market Share and Strategic Consolidations.

Pune, India - February 12, 2019 /MarketersMedia/ —

The women’s health therapy area covers medical disorders that affect females only, primarily disorders of the female reproductive system, including those associated with menstruation, conception, pregnancy, childbirth and menopause. Many of these disorders are highly prevalent among the female population.

The Women’s Health Market is relatively small considering the high prevalence of many women’s health indications. However, robust growth is projected over the forecast period due to the influx of a number of new products.

This report covers all indications within women’s health with a particular focus on five key indications: endometriosis, polycystic ovarian syndrome (PCOS), cervical intraepithelial neoplasia (CIN), menopausal disorders and infertility.

*Company Analysis and Positioning:
Revenue and Market Share Analysis by Company
1 Bayer AG - Company to Remain a Market Leader within Women’s Health
2 AbbVie Inc - Orilissa to Reach Blockbuster Status, Boosting Company’s Market Share
3 Allergan - Revenue Gains From Fibristal, Lo Loestrin Fe and Liletta to Offset Losses from Minastrin 24 Fe and Estrace
4 Merck & Co. - Company to Remain a Key Player Due to Growth of Gardasil/Gardasil 9
5 GlaxoSmithKline - Cervarix and Retosiban to Drive Strong Growth
6 Pfizer - How will patent expiration affect revenues for women’s health market?
7 TherapeuticsMD – Women’s Health Specialist to Gain Considerable Market Share by 2024

Get Discount on Global Women’s Health Drugs Market Research Report at https://www.reportsnreports.com/contacts/discount.aspx?name=1854865

Scope
- There are 277 pipeline products in active development for women’s health disorders. Which molecule types and molecular targets are most prominent within the pipeline?
- Merck&Co and Bayer currently represent leading companies within women’s health. Will they maintain this dominance over the forecast period?
- Gardasil, Mirena and Nuvaring and are among the most lucrative drugs within the women’s health market. Which of these will experience a considerable decline in revenue over the forecast period following loss of patent protection?
- The influx of a number of recent market entrants and late-stage pipeline products will have a considerable impact on the women’s health market over the forecast period. Which of these drugs are projected to achieve blockbuster status by 2024?
- In total, 246 licensing deals relating to women’s health products have been completed since 2006. Which types of assets attracted the largest deal values?

Direct Purchase of this Research Report at https://www.reportsnreports.com/purchase.aspx?name=1854865

Reasons to buy:
- Understand the current treatment landscape, with portfolios of key marketed products and a focus on historical and forecast sales patterns, and an overview of each drug’s mechanism of action.
- Analyze the women’s health pipeline through a comprehensive review of the pipeline segmented by stage of development, molecule type and molecular target.
- Consider market opportunities and potential risks by examining trends in clinical trial duration and size, as well as clinical trial failure rates.
- Predict growth in market size by examining multi-scenario forecasting trends from 2017 to 2024 and determine the contributions that different products and companies will make to this growth.
- Identify commercial opportunities in the women’s health deals landscape by analyzing trends in licensing and co-development deals.

Contact Info:
Name: Vishal Kalra
Email: Send Email
Organization: ReportsnReports
Website: https://www.reportsnreports.com/reports/1854865-global-womens-health-drugs-market-to-2024-influx-of-new-products-including-orilissa-relugolix-and-bremelanotide-to-diversify-landscape-and-drive-growth.html

Source URL: https://marketersmedia.com/global-womens-health-drugs-market-to-2024-influx-of-new-products-including-orilissa-relugolix-and-bremelanotide/481772

Source: MarketersMedia

Release ID: 481772

Latest News

With eyes on election, White House insists economy is strong

Aug 20, 2019

WASHINGTON — The "fundamentals" of the U.S. economy are solid, the White House asserted on Monday, invoking an ill-fated political declaration of a decade ago amid mounting concern that a recession could imperil President Donald Trump's reelection. Exhibiting no such concern, senior adviser Kellyanne Conway declared to reporters, "The fact is, the fundamentals of our economy are very strong," It's a phrase with a history. Republican John McCain was accused of being out of touch when he made a similar declaration during the 2008 presidential campaign just hours before investment bank Lehman Brothers filed for bankruptcy, setting off a stock...

Nebraska moves all girls out of facility for troubled youth

Aug 20, 2019

LINCOLN, Neb. — Nebraska officials are moving 24 teenage girls out of a state-run facility for female juvenile offenders after learning that many were confined to buildings with fire hazards, holes in the wall and mold and water damage. The Department of Health and Human Services announced the move Monday after some state lawmakers voiced concerns about the conditions and a lack of staff and programming at the Youth Rehabilitation and Treatment Center in Geneva. The campus in rural, central Nebraska serves as a rehabilitation center for girls ages 14-18 who have broken the law and been rejected by other...

Twitter shuts Chinese accounts targeting Hong Kong protests

Aug 20, 2019

WASHINGTON — Twitter said Monday it has suspended more than 200,000 accounts that it believes were part of a Chinese government influence campaign targeting the protest movement in Hong Kong. The company also said it will ban ads from state-backed media companies, expanding a prohibition it first applied in 2017 to two Russian entities. Both measures are part of what a senior company official portrayed in an interview as a broader effort by Twitter to curb malicious political activity on a popular platform that has been criticized for enabling election interference in the U.S. and around the world and for...

UK PM Boris Johnson faces rising Brexit strategy criticism

Aug 20, 2019

LONDON — British Prime Minister Boris Johnson is facing rising criticism of his Brexit strategy at home as he increases pressure on the European Union to re-open negotiations ahead of key meetings with his French and German counterparts later this week. The prime minister's office said Monday that the right of EU citizens to work in the U.K. without restrictions would end on Nov. 1 if Britain leaves the bloc without a Brexit deal. British government officials also rejected demands by lawmakers for Johnson to recall Parliament from its summer recess so that lawmakers can scrutinize the prime minister's Brexit...

Thousands flee from 'monster' wildfire on Canary Islands

Aug 20, 2019

LISBON, Portugal — A major, out-of-control wildfire in Spain's Canary Islands was throwing flames 50 meters (160 feet) into the air on Monday, forcing emergency workers to evacuate more than 9,000 people, authorities said. The blaze — described by the local fire department as "a monster" — was racing across parched woodlands into Tamadaba Natural Park, regarded as one of the jewels on Gran Canaria, a mountainous volcanic island in the Atlantic Ocean archipelago off northwest Africa. Famous for its beaches and mountains, Gran Canaria and its capital, Las Palmas, are popular European vacation destinations but the blaze was in...

Search

Deck Biz is an intelligent platform providing international and regional business news updates. You won’t get these insights elsewhere other than Deck Biz.

Contact us: sales@deckbiz.com